Athersys, Inc. (ATHX) Financial Analysis & Valuation | Quarter Chart
Athersys, Inc. (ATHX)
ATHXPrice: $0.01
Fair Value: 🔒
🔒score
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other co... more
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the f... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Z. Kasey Rosado |
| IPO Date | 2007-06-12 | CAGR | 0.05% |
| Employees | 24 | Website | www.athersys.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ATHX chart loading...
Fundamentals
Technicals
| Enterprise Value | $28.14M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | -0.01 |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $-1.65 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -98.67% | Gross Margin | 1% |
| Operating Margin | -14.46% | Profit Margin | -12.78% |
| ROE | 18.19% | ROA | -2.45% |
| ROCE | 5.26% | Current Ratio | 0.32 |
| Quick Ratio | 0.32 | Cash Ratio | 0.21 |
| Debt/Equity | -0.36 | Interest Coverage | — |
| Altman Z Score | -152.57 | Piotroski Score | 2 |